Gene Matters
Minneapolis, US · Founded 2016 · Delaware corporation · 1 known investors
Founders & leadership
DJ
Danny J. CunaginNamed on SEC filing
JD
Jill DaviesNamed on SEC filing
ME
Mark E. SylvesterNamed on SEC filing
TD
Troy D. KopischkeNamed on SEC filing
BB
Brent BackhausNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$10.3M disclosed across 2 of 3 rounds · 2017–2020
▶$10.2MraisedJul 2020 · 8 investors · Other TechnologyRule 506(b)
▶$10.2MraisedJul 2020 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brent BackhausDirector
- Mark SylvesterExecutive Officer
- Troy KopischkeDirector
- Danny CunaginDirector
- Jill DaviesExecutive Officer, Director
- Offering amount
- $10.2M
- Amount sold
- $10.2M
- First sale
- Jul 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$130KraisedMay 2019 · 2 investors · Other TechnologyRule 506(b)
▶$130KraisedMay 2019 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Danny J. CunaginDirector
- Brent BackhausExecutive Officer
- Steve TroutnerDirector
- Mark E. SylvesterExecutive Officer
- Jill DaviesExecutive Officer, Director
- Troy D. KopischkeExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $130K
- Minimum investment
- $70K
- First sale
- Apr 2019
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
▶$1MofferedJun 2017 · Other TechnologyRule 506(b)
▶$1MofferedJun 2017 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Danny J. CunaginDirector
- Jill DaviesExecutive Officer, Director
- Mark E. SylvesterExecutive Officer
- Troy D. KopischkeExecutive Officer, Director
- Brent BackhausExecutive Officer
- Offering amount
- $1M
- Minimum investment
- $50K
- Proceeds to insiders
- $480K
- Incorporated
- Limited Liability Company, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Gene Matters's investors?
- Gene Matters's investors include iSelect Fund.
- How much funding has Gene Matters raised?
- Gene Matters has disclosed $10.3M raised across 2 of its 3 known rounds.
- Where is Gene Matters headquartered?
- Gene Matters is headquartered in Minneapolis, US.